ID   PGL3_CAEEL              Reviewed;         693 AA.
AC   G5EBV6; Q965J2;
DT   31-JAN-2018, integrated into UniProtKB/Swiss-Prot.
DT   14-DEC-2011, sequence version 1.
DT   18-JUN-2025, entry version 94.
DE   RecName: Full=Guanyl-specific ribonuclease pgl-3 {ECO:0000305};
DE            EC=4.6.1.24 {ECO:0000269|PubMed:26787882};
DE   AltName: Full=P granule abnormality protein 3 {ECO:0000312|WormBase:C18G1.4a};
GN   Name=pgl-3 {ECO:0000312|WormBase:C18G1.4a};
GN   ORFNames=C18G1.4 {ECO:0000312|WormBase:C18G1.4a};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239 {ECO:0000312|Proteomes:UP000001940};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH PGL-1 AND PGL-2,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, DOMAIN, AND
RP   DISRUPTION PHENOTYPE.
RX   PubMed=15238518; DOI=10.1534/genetics.103.023093;
RA   Kawasaki I., Amiri A., Fan Y., Meyer N., Dunkelbarger S., Motohashi T.,
RA   Karashima T., Bossinger O., Strome S.;
RT   "The PGL family proteins associate with germ granules and function
RT   redundantly in Caenorhabditis elegans germline development.";
RL   Genetics 167:645-661(2004).
RN   [2] {ECO:0000312|Proteomes:UP000001940}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2 {ECO:0000312|Proteomes:UP000001940};
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
RN   [3] {ECO:0000305}
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=19372764; DOI=10.4161/auto.5.5.8552;
RA   Zhao Y., Tian E., Zhang H.;
RT   "Selective autophagic degradation of maternally-loaded germline P granule
RT   components in somatic cells during C. elegans embryogenesis.";
RL   Autophagy 5:717-719(2009).
RN   [4] {ECO:0000305}
RP   FUNCTION, INTERACTION WITH SEPA-1, SUBCELLULAR LOCATION, DEVELOPMENTAL
RP   STAGE, AND DISRUPTION PHENOTYPE.
RX   PubMed=19167332; DOI=10.1016/j.cell.2008.12.022;
RA   Zhang Y., Yan L., Zhou Z., Yang P., Tian E., Zhang K., Zhao Y., Li Z.,
RA   Song B., Han J., Miao L., Zhang H.;
RT   "SEPA-1 mediates the specific recognition and degradation of P granule
RT   components by autophagy in C. elegans.";
RL   Cell 136:308-321(2009).
RN   [5] {ECO:0000305}
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, DOMAIN, DISRUPTION PHENOTYPE, AND
RP   MUTAGENESIS OF 633-GLY--GLY-692.
RX   PubMed=21402787; DOI=10.1083/jcb.201010106;
RA   Hanazawa M., Yonetani M., Sugimoto A.;
RT   "PGL proteins self associate and bind RNPs to mediate germ granule assembly
RT   in C. elegans.";
RL   J. Cell Biol. 192:929-937(2011).
RN   [6] {ECO:0000305}
RP   FUNCTION, INTERACTION WITH PRMT-1 AND SEPA-1, SUBCELLULAR LOCATION,
RP   METHYLATION, AND MUTAGENESIS OF ARG-641; ARG-650; ARG-658; ARG-661;
RP   ARG-665; ARG-668; ARG-676; ARG-682 AND ARG-690.
RX   PubMed=24140420; DOI=10.1016/j.molcel.2013.09.014;
RA   Li S., Yang P., Tian E., Zhang H.;
RT   "Arginine methylation modulates autophagic degradation of PGL granules in
RT   C. elegans.";
RL   Mol. Cell 52:421-433(2013).
RN   [7] {ECO:0000305}
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=24746798; DOI=10.1016/j.cub.2014.03.015;
RA   Updike D.L., Knutson A.K., Egelhofer T.A., Campbell A.C., Strome S.;
RT   "Germ-granule components prevent somatic development in the C. elegans
RT   germline.";
RL   Curr. Biol. 24:970-975(2014).
RN   [8] {ECO:0000305}
RP   IDENTIFICATION BY MASS SPECTROMETRY, FUNCTION, SUBCELLULAR LOCATION,
RP   DOMAIN, AND MUTAGENESIS OF ARG-634; ARG-638; ARG-650; ARG-661; ARG-665 AND
RP   ARG-690.
RX   PubMed=27594427; DOI=10.1016/j.cell.2016.08.006;
RA   Saha S., Weber C.A., Nousch M., Adame-Arana O., Hoege C., Hein M.Y.,
RA   Osborne-Nishimura E., Mahamid J., Jahnel M., Jawerth L., Pozniakovski A.,
RA   Eckmann C.R., Juelicher F., Hyman A.A.;
RT   "Polar positioning of phase-separated liquid compartments in cells
RT   regulated by an mRNA competition mechanism.";
RL   Cell 166:1572-1584(2016).
RN   [9] {ECO:0000305}
RP   FUNCTION, SUBCELLULAR LOCATION, AND DISRUPTION PHENOTYPE.
RX   PubMed=26598553; DOI=10.1242/jcs.174201;
RA   Min H., Shim Y.H., Kawasaki I.;
RT   "Loss of PGL-1 and PGL-3, members of a family of constitutive germ-granule
RT   components, promotes germline apoptosis in C. elegans.";
RL   J. Cell Sci. 129:341-353(2016).
RN   [10] {ECO:0000305}
RP   FUNCTION, CATALYTIC ACTIVITY, SUBUNIT, AND DOMAIN.
RX   PubMed=26787882; DOI=10.1073/pnas.1524400113;
RA   Aoki S.T., Kershner A.M., Bingman C.A., Wickens M., Kimble J.;
RT   "PGL germ granule assembly protein is a base-specific, single-stranded
RT   RNase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 113:1279-1284(2016).
RN   [11] {ECO:0000305}
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE,
RP   AND DISRUPTION PHENOTYPE.
RX   PubMed=27650246; DOI=10.1038/srep33884;
RA   Al-Amin M., Min H., Shim Y.H., Kawasaki I.;
RT   "Somatically expressed germ-granule components, PGL-1 and PGL-3, repress
RT   programmed cell death in C. elegans.";
RL   Sci. Rep. 6:33884-33884(2016).
RN   [12] {ECO:0000305}
RP   FUNCTION, SUBCELLULAR LOCATION, AND DEVELOPMENTAL STAGE.
RX   PubMed=28806108; DOI=10.1080/15548627.2017.1339843;
RA   Zhang G., Lin L., Qi D., Zhang H.;
RT   "The composition of a protein aggregate modulates the specificity and
RT   efficiency of its autophagic degradation.";
RL   Autophagy 13:1487-1495(2017).
CC   -!- FUNCTION: Guanyl-specific endoribonuclease which cleaves the
CC       phosphodiester bond in single-stranded RNA between the 3'-guanylic
CC       residue and the 5'-OH residue of adjacent nucleotide, resulting in the
CC       formation of a corresponding 2',3'-cyclic phosphate intermediate
CC       (PubMed:26787882). P-granule component involved in germline development
CC       (PubMed:15238518, PubMed:19372764, PubMed:24746798). Together with the
CC       P-granule component pgl-1, is involved in the formation of P-granules
CC       (PubMed:21402787, PubMed:24746798, PubMed:27594427). Together with pgl-
CC       1, probably recruits other granule components such as pos-1, mex-3 and
CC       glh-1, and RNA to P-granules (PubMed:21402787, PubMed:27594427). In
CC       vitro, binds mRNA; this interaction is required for the formation of
CC       liquid-like droplets that resemble P-granules (PubMed:27594427). Most
CC       likely recruits pgl-1 into P-granules during autophagy
CC       (PubMed:19167332). Associates with adapters such as sepa-1 and is
CC       required for the accumulation and degradation of P-granules by
CC       autophagy in somatic cells (PubMed:19167332, PubMed:24140420,
CC       PubMed:28806108). This ensures exclusive localization of the P-granules
CC       in germ cells (PubMed:19167332, PubMed:28806108). In addition, may act
CC       redundantly with pgl-1 to protect germ cells from excessive germline
CC       apoptosis during normal oogenesis and development of the two gonadal
CC       arms (PubMed:26598553). This may in part be through regulating the
CC       localization of sir-2.1 which is involved in germ cell apoptosis
CC       (PubMed:26598553). May protect somatic cells from excessive apoptosis
CC       during normal development (PubMed:27650246).
CC       {ECO:0000269|PubMed:15238518, ECO:0000269|PubMed:19167332,
CC       ECO:0000269|PubMed:19372764, ECO:0000269|PubMed:21402787,
CC       ECO:0000269|PubMed:24140420, ECO:0000269|PubMed:24746798,
CC       ECO:0000269|PubMed:26598553, ECO:0000269|PubMed:26787882,
CC       ECO:0000269|PubMed:27594427, ECO:0000269|PubMed:27650246,
CC       ECO:0000269|PubMed:28806108}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[RNA] containing guanosine + H2O = an [RNA fragment]-3'-
CC         guanosine-3'-phosphate + a 5'-hydroxy-ribonucleotide-3'-[RNA
CC         fragment].; EC=4.6.1.24; Evidence={ECO:0000269|PubMed:26787882};
CC   -!- SUBUNIT: May form a homodimer (PubMed:21402787, PubMed:26787882).
CC       Interacts with pgl-1 and pgl-2; this association is not required for P-
CC       granule localization of either pgl-1 or pgl-2 (PubMed:15238518).
CC       Interacts with sepa-1; the interaction is enhanced in the presence of
CC       RNA (PubMed:19167332, PubMed:24140420). Interacts with prmt-1; the
CC       interaction is direct (PubMed:24140420). {ECO:0000269|PubMed:15238518,
CC       ECO:0000269|PubMed:19167332, ECO:0000269|PubMed:24140420,
CC       ECO:0000269|PubMed:26787882, ECO:0000303|PubMed:21402787}.
CC   -!- INTERACTION:
CC       G5EBV6; G5EC37: sepa-1; NbExp=5; IntAct=EBI-328338, EBI-2256317;
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic granule {ECO:0000269|PubMed:15238518,
CC       ECO:0000269|PubMed:19372764, ECO:0000269|PubMed:21402787,
CC       ECO:0000269|PubMed:24140420, ECO:0000269|PubMed:26598553,
CC       ECO:0000269|PubMed:27594427, ECO:0000269|PubMed:27650246,
CC       ECO:0000269|PubMed:28806108, ECO:0000305|PubMed:19167332}.
CC       Note=Localizes to P granules in germ cells at all stages of development
CC       except in spermatogenesis (PubMed:15238518). Localizes to the germ
CC       precursor cells Z2 and Z3 in embryos (PubMed:19372764, PubMed:24140420,
CC       PubMed:27650246). Co-localizes with pgl-1 in P-granules, but
CC       localization in P-granules is not dependent on an association with pgl-
CC       1 (PubMed:15238518, PubMed:21402787). {ECO:0000269|PubMed:15238518,
CC       ECO:0000269|PubMed:19372764, ECO:0000269|PubMed:21402787,
CC       ECO:0000269|PubMed:24140420, ECO:0000269|PubMed:27650246}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=a {ECO:0000312|WormBase:C18G1.4a};
CC         IsoId=G5EBV6-1; Sequence=Displayed;
CC       Name=b {ECO:0000312|WormBase:C18G1.4b};
CC         IsoId=G5EBV6-2; Sequence=VSP_059308;
CC   -!- TISSUE SPECIFICITY: Highly expressed in the germline (PubMed:15238518).
CC       Expressed in most somatic cells (PubMed:27650246).
CC       {ECO:0000269|PubMed:15238518, ECO:0000269|PubMed:27650246}.
CC   -!- DEVELOPMENTAL STAGE: Expressed throughout development from embryos to
CC       adults (PubMed:15238518, PubMed:27650246). Not expressed in somatic
CC       cells of embryos (PubMed:28806108). First expressed in 1-cell embryos,
CC       and expression continues until the 24-cell stage (PubMed:15238518).
CC       Highly expressed in early stage embryos (PubMed:19167332). Expression
CC       decreases after the 24-cell stage and is negligible throughout the rest
CC       of embryogenesis and early stages of larval development
CC       (PubMed:15238518, PubMed:19167332). During larval development, first
CC       expressed in the germline of L3 stage larvae (PubMed:15238518).
CC       {ECO:0000269|PubMed:15238518, ECO:0000269|PubMed:19167332,
CC       ECO:0000269|PubMed:27650246, ECO:0000269|PubMed:28806108}.
CC   -!- DOMAIN: The dimerization domain also acts as a hinge; changes in its
CC       structure probably impact oligomerization and RNA-binding.
CC       {ECO:0000305|PubMed:26787882}.
CC   -!- DOMAIN: The RNA-binding RGG-box is required for the recruitment of some
CC       P-granule components such as pos-1 and probably mRNA, but is
CC       dispensable for granule formation. {ECO:0000269|PubMed:21402787,
CC       ECO:0000305|PubMed:15238518, ECO:0000305|PubMed:27594427}.
CC   -!- PTM: Methylated at arginine residues in the RNA-binding RGG-box by
CC       prmt-1. Methylation promotes P-granule degradation by autophagy.
CC       {ECO:0000269|PubMed:24140420}.
CC   -!- DISRUPTION PHENOTYPE: Viable, and not temperature sensitive
CC       (PubMed:15238518). Failed degradation and diffuse cytoplasmic
CC       localization of the P-granule component pgl-1 in the somatic cells of
CC       embryos (PubMed:19167332). Increased germ cell apoptosis in gonadal
CC       arms, and this is further increased following UV irradiation
CC       (PubMed:26598553). Double knockout with pgl-1 results in 37% of progeny
CC       arresting as late embryos and 9% as larvae at 26 degrees Celsius
CC       (PubMed:15238518). Double knockout with pgl-1 enhances the temperature-
CC       sensitive sterility phenotype and germline defects of the pgl-1 single
CC       knockout (PubMed:15238518, PubMed:26598553). Germline defects include
CC       increased apoptosis in the gonad, fewer germ nuclei, no sperm and no
CC       oocytes in the gonad arms (PubMed:15238518, PubMed:26598553). The
CC       gonads of the double knockout with pgl-1 degenerate as the adults age
CC       (PubMed:15238518). Conversely, double knockout with ced-1 results in
CC       reduced somatic cell apoptosis (PubMed:27650246). Triple knockout with
CC       pgl-1 and pgl-2 results in 58% of progeny arresting as late embryos and
CC       5% as larvae at 26 degrees Celsius (PubMed:15238518). Triple knockout
CC       with pgl-1 and him-3 further reduces the number of self-cross progeny
CC       as compared to the pgl-1 and him-3 double mutant and him-3 single
CC       mutant (PubMed:15238518). Double RNAi-mediated knockdown with pgl-1
CC       results in a reduced number of pos-1, mex-1 and glh-1 positive granules
CC       in embryos (PubMed:21402787). Quadruple RNAi-mediated knockdown with
CC       glh-1, glh-4 and pgl-1 results in offspring that display 27-89%
CC       sterility, abnormal oocytes and do not have embryos in the uterus
CC       (PubMed:24746798). These sterile offspring still produce sperm
CC       (PubMed:24746798). Furthermore, these offspring may have compromised P-
CC       granule integrity as there is diffuse cytoplasmic localization of the
CC       P-granule component deps-1, which may cause germ cells to initiate
CC       somatic reprogramming (PubMed:24746798). RNAi-mediated knockdown in a
CC       double ced-1 and hpl-2 mutant background rescues the reduced somatic
CC       cell apoptotic cell defect in the ced-1 and hpl-2 double knockout at 25
CC       degrees Celsius (PubMed:27650246). {ECO:0000269|PubMed:15238518,
CC       ECO:0000269|PubMed:19167332, ECO:0000269|PubMed:21402787,
CC       ECO:0000269|PubMed:24746798, ECO:0000269|PubMed:26598553,
CC       ECO:0000269|PubMed:27650246}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB120729; BAC87886.1; -; mRNA.
DR   EMBL; BX284605; CCD65226.1; -; Genomic_DNA.
DR   EMBL; BX284605; CCD65227.1; -; Genomic_DNA.
DR   PIR; T33251; T33251.
DR   RefSeq; NP_504278.1; NM_071877.7. [G5EBV6-1]
DR   RefSeq; NP_504279.1; NM_071878.5. [G5EBV6-2]
DR   AlphaFoldDB; G5EBV6; -.
DR   SMR; G5EBV6; -.
DR   FunCoup; G5EBV6; 150.
DR   IntAct; G5EBV6; 1.
DR   STRING; 6239.C18G1.4a.1; -.
DR   PaxDb; 6239-C18G1.4a; -.
DR   PeptideAtlas; G5EBV6; -.
DR   EnsemblMetazoa; C18G1.4a.1; C18G1.4a.1; WBGene00003994. [G5EBV6-1]
DR   EnsemblMetazoa; C18G1.4b.1; C18G1.4b.1; WBGene00003994. [G5EBV6-2]
DR   GeneID; 178867; -.
DR   KEGG; cel:CELE_C18G1.4; -.
DR   UCSC; C18G1.4a; c. elegans.
DR   AGR; WB:WBGene00003994; -.
DR   CTD; 178867; -.
DR   WormBase; C18G1.4a; CE17420; WBGene00003994; pgl-3. [G5EBV6-1]
DR   WormBase; C18G1.4b; CE27717; WBGene00003994; pgl-3. [G5EBV6-2]
DR   eggNOG; ENOG502QVYU; Eukaryota.
DR   GeneTree; ENSGT00970000196090; -.
DR   HOGENOM; CLU_362575_0_0_1; -.
DR   InParanoid; G5EBV6; -.
DR   OMA; ALWITEF; -.
DR   OrthoDB; 5830648at2759; -.
DR   PhylomeDB; G5EBV6; -.
DR   CD-CODE; 0F0CDB11; Synthetic Condensate 000073.
DR   CD-CODE; 0F455885; Synthetic Condensate 000172.
DR   CD-CODE; 73A75392; P-granule.
DR   CD-CODE; 75CAE956; Synthetic Condensate 000075.
DR   CD-CODE; 7DC50CA0; Synthetic Condensate 000067.
DR   CD-CODE; 985E7A25; Synthetic Condensate 000077.
DR   CD-CODE; B30D3E4B; Synthetic Condensate 000234.
DR   CD-CODE; F6300417; Synthetic Condensate 000082.
DR   PRO; PR:G5EBV6; -.
DR   Proteomes; UP000001940; Chromosome V.
DR   Bgee; WBGene00003994; Expressed in adult organism and 3 other cell types or tissues.
DR   GO; GO:0043229; C:intracellular organelle; IDA:WormBase.
DR   GO; GO:0043186; C:P granule; IDA:WormBase.
DR   GO; GO:0042802; F:identical protein binding; IPI:WormBase.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046589; F:ribonuclease T1 activity; IEA:UniProtKB-EC.
DR   GO; GO:0003723; F:RNA binding; ISS:WormBase.
DR   GO; GO:0004521; F:RNA endonuclease activity; IDA:WormBase.
PE   1: Evidence at protein level;
KW   Alternative splicing; Developmental protein; Endonuclease; Hydrolase;
KW   Lyase; Methylation; Nuclease; Reference proteome; RNA-binding.
FT   CHAIN           1..693
FT                   /note="Guanyl-specific ribonuclease pgl-3"
FT                   /evidence="ECO:0000305"
FT                   /id="PRO_0000443017"
FT   REGION          205..447
FT                   /note="Involved in dimerization"
FT                   /evidence="ECO:0000269|PubMed:26787882"
FT   REGION          445..468
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          523..591
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          581..614
FT                   /note="Required for interaction with sepa-1"
FT                   /evidence="ECO:0000269|PubMed:19167332"
FT   REGION          620..693
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          633..693
FT                   /note="RNA-binding RGG-box"
FT                   /evidence="ECO:0000269|PubMed:27594427,
FT                   ECO:0000305|PubMed:15238518"
FT   COMPBIAS        447..468
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        528..548
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        569..580
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        625..634
FT                   /note="Gly residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        641..660
FT                   /note="Gly residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        668..693
FT                   /note="Gly residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        437
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:Q9TZQ3"
FT   VAR_SEQ         1..88
FT                   /note="MEANKRQIVEVDGIKSYFFPHLAHYLASNDELLVNNIAQANKLAAFVLGATD
FT                   KRPSNEEIAEMILPNDSSAYVLAAGMDVCLILGDDF -> MTPVPTCLLLAWTFALFSG
FT                   MTSL (in isoform b)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_059308"
FT   MUTAGEN         627
FT                   /note="R->A: No effect on methylation of the RNA-binding
FT                   RGG-box."
FT                   /evidence="ECO:0000269|PubMed:24140420"
FT   MUTAGEN         633..692
FT                   /note="Missing: Globular cytoplasmic granules form, but do
FT                   not contain the P-granule components such as pos-1."
FT                   /evidence="ECO:0000269|PubMed:21402787"
FT   MUTAGEN         634
FT                   /note="R->A: No effect on methylation of the RNA-binding
FT                   RGG-box."
FT                   /evidence="ECO:0000269|PubMed:24140420"
FT   MUTAGEN         634
FT                   /note="R->L: Abolishes RNA-binding; when associated with
FT                   G-638; L-650; G-661; G-665 and G-690."
FT                   /evidence="ECO:0000269|PubMed:27594427"
FT   MUTAGEN         638
FT                   /note="R->A: No effect on methylation of the RNA-binding
FT                   RGG-box."
FT                   /evidence="ECO:0000269|PubMed:24140420"
FT   MUTAGEN         638
FT                   /note="R->G: Abolishes RNA-binding; when associated with
FT                   L-634; L-650; G-661; G-665 and G-690."
FT                   /evidence="ECO:0000269|PubMed:27594427"
FT   MUTAGEN         641
FT                   /note="R->A: Reduces methylation of the RNA-binding
FT                   RGG-box. Abolishes methylation of the RNA-binding RGG-box;
FT                   when associated with A-650; A-658; A-661; A-665; A-668;
FT                   A-676; A-682 and A-690."
FT                   /evidence="ECO:0000269|PubMed:24140420"
FT   MUTAGEN         648
FT                   /note="R->A: No effect on methylation of the RNA-binding
FT                   RGG-box."
FT                   /evidence="ECO:0000269|PubMed:24140420"
FT   MUTAGEN         650
FT                   /note="R->A: Reduces methylation of the RNA-binding
FT                   RGG-box. Abolishes methylation of the RNA-binding RGG-box;
FT                   when associated with A-641; A-658; A-661; A-665; A-668;
FT                   A-676; A-682 and A-690."
FT                   /evidence="ECO:0000269|PubMed:24140420"
FT   MUTAGEN         650
FT                   /note="R->L: Abolishes RNA-binding; when associated with
FT                   L-634; G-638; G-661; G-665 and G-690."
FT                   /evidence="ECO:0000269|PubMed:27594427"
FT   MUTAGEN         658
FT                   /note="R->A: Reduces methylation of the RNA-binding
FT                   RGG-box. Abolishes methylation of the RNA-binding RGG-box;
FT                   when associated with A-641; A-650; A-661; A-665; A-668;
FT                   A-676; A-682 and A-690."
FT                   /evidence="ECO:0000269|PubMed:24140420"
FT   MUTAGEN         661
FT                   /note="R->A: Reduces methylation of the RNA-binding
FT                   RGG-box. Abolishes methylation of the RNA-binding RGG-box;
FT                   when associated with A-641; A-650; A-658; A-665; A-668;
FT                   A-676; A-682 and A-690."
FT                   /evidence="ECO:0000269|PubMed:24140420"
FT   MUTAGEN         661
FT                   /note="R->G: Abolishes RNA-binding; when associated with
FT                   L-634; G-638; L-650; G-665 and G-690."
FT                   /evidence="ECO:0000269|PubMed:27594427"
FT   MUTAGEN         665
FT                   /note="R->A: Reduces methylation of the RNA-binding
FT                   RGG-box. Abolishes methylation of the RNA-binding RGG-box;
FT                   when associated with A-641; A-650; A-658; A-661; A-668;
FT                   A-676; A-682 and A-690."
FT                   /evidence="ECO:0000269|PubMed:24140420"
FT   MUTAGEN         665
FT                   /note="R->G: Abolishes RNA-binding; when associated with
FT                   L-634; G-638; L-650; G-661 and G-690."
FT                   /evidence="ECO:0000269|PubMed:27594427"
FT   MUTAGEN         668
FT                   /note="R->A: Reduces methylation of the RNA-binding
FT                   RGG-box. Abolishes methylation of the RNA-binding RGG-box;
FT                   when associated with A-641; A-650; A-658; A-661; A-665;
FT                   A-676; A-682 and A-690."
FT                   /evidence="ECO:0000269|PubMed:24140420"
FT   MUTAGEN         676
FT                   /note="R->A: Reduces methylation of the RNA-binding
FT                   RGG-box. Abolishes methylation of the RNA-binding RGG-box;
FT                   when associated with A-641; A-650; A-658; A-661; A-665;
FT                   A-668; A-682 and A-690."
FT                   /evidence="ECO:0000269|PubMed:24140420"
FT   MUTAGEN         682
FT                   /note="R->A: Reduces methylation of the RNA-binding
FT                   RGG-box. Abolishes methylation of the RNA-binding RGG-box;
FT                   when associated with A-641; A-650; A-658; A-661; A-665;
FT                   A-668; A-676 and A-690."
FT                   /evidence="ECO:0000269|PubMed:24140420"
FT   MUTAGEN         690
FT                   /note="R->A: Reduces methylation of the RNA-binding
FT                   RGG-box. Abolishes methylation of the RNA-binding RGG-box;
FT                   when associated with A-641; A-650; A-658; A-661; A-665;
FT                   A-668; A-676 and A-682."
FT                   /evidence="ECO:0000269|PubMed:24140420"
FT   MUTAGEN         690
FT                   /note="R->G: Abolishes RNA-binding; when associated with
FT                   L-634; G-638; L-650; G-661 and G-665."
FT                   /evidence="ECO:0000269|PubMed:27594427"
SQ   SEQUENCE   693 AA;  74845 MW;  16DA54282F3D8CB0 CRC64;
     MEANKRQIVE VDGIKSYFFP HLAHYLASND ELLVNNIAQA NKLAAFVLGA TDKRPSNEEI
     AEMILPNDSS AYVLAAGMDV CLILGDDFRP KFDSGAEKLS QLGQAHDLAP IIDDEKKISM
     LARKTKLKKS NDAKILQVLL KVLGAEEAEE KFVELSELSS ALDLDFDVYV LAKLLGFASE
     ELQEEIEIIR DNVTDAFEAC KPLLKKLMIE GPKIDSVDPF TQLLLTPQEE SIEKAVSHIV
     ARFEEASAVE DDESLVLKSQ LGYQLIFLVV RSLADGKRDA SRTIQSLMPS SVRAEVFPGL
     QRSVFKSAVF LASHIIQVFL GSMKSFEDWA FVGLAEDLES TWRRRAIAEL LKKFRISVLE
     QCFSQPIPLL PQSELNNETV IENVNNALQF ALWITEFYGS ESEKKSLNQL QFLSPKSKNL
     LVDSFKKFAQ GLDSKDHVNR IIESLEKSSS SEPSATAKQT TTSNGPTTVS TAAQVVTVEK
     MPFSRQTIPC EGTDLANVLN SAKIIGESVT VAAHDVIPEK LNAEKNDNTP STASPVQFSS
     DGWDSPTKSV ALPPKISTLE EEQEEDTTIT KVSPQPQERT GTAWGSGDAT PVPLATPVNE
     YKVSGFGAAP VASGFGQFAS SNGTSGRGSY GGGRGGDRGG RGAYGGDRGR GGSGDGSRGY
     RGGDRGGRGS YGEGSRGYQG GRAGFFGGSR GGS
//
